Immune-boosting effect of Pegasys provides patients with the chance for a clinical cure
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
New England Journal of Medicine publishes results from the landmark ATHENA trial
- Details
- Category: Sanofi
![Sanofi-aventis Sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Sandoz receives European Commission approval for biosimilar filgrastim
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Novartis gains worldwide rights to elinogrel, a Phase II anti-clotting compound
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
HemCon Announces Further Successful Results from Live Nail Infection Anti-Fungal Study
- Details
- Category: Product
HemCon Medical Technologies, Inc. has announced results from an independent study investigating the time required to successfully treat fungal infected human nails which is a leading cause of Onychomycosis. The studies were conducted as part of HemCon's continued program of development for a formulation based on its newest proprietary platform technology.
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
More Pharma News ...
- Pfizer to Disclose Payments to US Physicians, Healthcare Professionals and Clinical Investigators
- GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899
- Lundbeck to acquire US-based Ovation Pharmaceuticals, Inc.
- Pfizer and The Pfizer Foundation Recognize "World Cancer Day"
- European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim)
- European Commission Clears Acquisition of Zentiva NV by sanofi-aventis
- Strong operating results for Roche in 2008